US Broker Ratings

The Cooper Companies, Inc. (COO)

⚠️ No article content returned.

..

Ascendis Pharma A/S (ASND) Stock Analysis: Strong Buy Ratings and Double-Digit Revenue Growth Spark Investor Interest

Ascendis Pharma A/S (NASDAQ: ASND), a Danish biotechnology company, is capturing the attention of investors with its impressive revenue growth and strong analyst ratings. Operating in the healthcare sector, Ascendis..

Molina Healthcare Inc (MOH): Investor Outlook Amidst Revenue Challenges and Analyst Ratings

Molina Healthcare Inc (NYSE: MOH) stands as a significant player in the healthcare plans industry, particularly focusing on providing managed healthcare services to low-income families and individuals through Medicaid, Medicare,..

Bristol-Myers Squibb (BMY) Stock Analysis: Exploring the 9.67% Potential Upside for Investors

Bristol-Myers Squibb Company (NYSE: BMY), a stalwart in the healthcare sector, is a global biopharmaceutical leader with a rich history dating back to 1887. Headquartered in Princeton, New Jersey, the..

HCA Healthcare, Inc. (HCA) Investor Outlook: Exploring a 27.73% Potential Upside Amidst Steady Revenue Growth

HCA Healthcare, Inc. (NYSE: HCA), a behemoth in the medical care facilities industry, is currently captivating the attention of investors with its promising financial indicators and robust market presence. With..

Henry Schein, Inc. (HSIC) Stock Analysis: Navigating Growth with a 3.67% Potential Upside

Henry Schein, Inc. (NASDAQ: HSIC) is a formidable player in the healthcare sector, specifically within the medical distribution industry. Headquartered in Melville, New York, the company has carved out a..

Haleon plc (HLN) Stock Analysis: Exploring a 26.52% Potential Upside in the Healthcare Sector

Haleon plc (HLN), a prominent player in the healthcare sector, is capturing investor attention with its strong market presence and promising potential upside of 26.52%. As a United Kingdom-based company,..

Genmab A/S (GMAB) Investor Outlook: Exploring a 40.96% Potential Upside in the Biotech Sector

For investors seeking opportunities in the biotechnology sector, Genmab A/S (NASDAQ: GMAB) presents a compelling case. With a market capitalization of $16.04 billion, this Danish healthcare company specializes in developing..

Insmed Incorporated (INSM) Stock Analysis: Strong Buy Ratings and a 90% Upside Potential

Investors looking for opportunities in the biotechnology sector may find Insmed Incorporated (NASDAQ: INSM) an intriguing prospect. This healthcare company, headquartered in Bridgewater, New Jersey, is focused on developing and..

Koninklijke Philips N.V. (PHG): Stock Analysis Highlights 23.76% Upside Potential for Investors

Investors eyeing opportunities in the healthcare sector may find Koninklijke Philips N.V. (NYSE: PHG) an intriguing prospect. With its headquarters in Amsterdam, Netherlands, Philips is a global leader in health..

McKesson Corporation (MCK) Stock Analysis: Exploring a 23.3% Potential Upside in the Healthcare Giant

McKesson Corporation (NYSE: MCK), a stalwart in the healthcare sector, stands as a formidable player in the medical distribution industry. With a market capitalization of approximately $89.39 billion, McKesson is..

Baxter International Inc. (BAX) Stock Analysis: Navigating Challenges with a Focus on Free Cash Flow

For investors keeping a keen eye on the healthcare sector, Baxter International Inc. (NYSE: BAX) represents a compelling case study. With a market capitalization standing at $11.38 billion, Baxter is..

Elevance Health, Inc. (ELV) Stock Analysis: Discovering Growth Potential in Healthcare Plans

Elevance Health, Inc. (NYSE: ELV), formerly known as Anthem, Inc., stands as a formidable player in the healthcare sector with a market capitalization of $85.82 billion. Based in Indianapolis, Indiana,..

AstraZeneca PLC (AZN) Stock Analysis: Exploring a 19% Upside and Robust Revenue Growth

AstraZeneca PLC (AZN), a titan in the healthcare sector, continues to draw attention from investors with its impressive market cap of $292.2 billion and a promising potential upside of 19.15%...

Mettler-Toledo International, I (MTD) Stock Analysis: A Healthcare Giant with a 3.75% Potential Upside

Mettler-Toledo International Inc. (NYSE: MTD), a prominent player in the healthcare sector specializing in diagnostics and research, presents a compelling case for investors seeking opportunities in precision instruments and services...

DexCom, Inc. (DXCM) Investor Outlook: Seizing a 21.53% Upside in the Booming CGM Market

DexCom, Inc. (NASDAQ: DXCM), a leader in the healthcare sector, continues to capture investor interest with its innovative continuous glucose monitoring (CGM) systems. As a key player in the medical..

Danaher Corporation (DHR) Stock Analysis: Unpacking a 23.53% Potential Upside for Investors

Danaher Corporation (NYSE: DHR), a giant in the healthcare sector, is capturing the interest of investors with its significant market cap of $138.86 billion and an enticing potential upside of..

Labcorp Holdings Inc. (LH) Investor Outlook: Strong Buy Ratings Signal 14% Potential Upside

Labcorp Holdings Inc. (LH) stands as a prominent player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Burlington, North Carolina, Labcorp has built a reputation..

Novartis AG (NVS) Stock Analysis: Solid Dividend Yield and Strong ROE Attract Investors Despite Minimal Upside

Novartis AG (NYSE: NVS), a Swiss pharmaceutical giant, is a stalwart in the healthcare sector, renowned for its robust pipeline of innovative medicines. With a market capitalization of $296.54 billion,..

STERIS plc (STE) Stock Analysis: Healthcare Giant Poised for 19% Upside

STERIS plc (NYSE: STE), a prominent player in the healthcare sector specializing in medical devices, offers a compelling investment opportunity with a potential upside of 19.10%. With its robust market..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds